Yuhan Corp. said Tuesday it has begun commercializing its artificial intelligence telemetry solution, MemoCue, in partnership with digital health care company Huino.
The companies will supply the system to about 100 beds in key departments at H Plus Yangji Hospital where cardiac monitoring is considered essential, Yuhan said.
MemoCue analyzes hospitalized patients’ electrocardiogram data in real time to detect abnormal signs early and support clinicians’ decisions. It is designed to extend monitoring beyond intensive care units to general wards.
Yuhan said the system can use a hospital’s existing communications infrastructure without installing a separate network gateway, reducing the burden of adoption.
The solution includes a wearable electrocardiograph, the Memo Patch M, designed with patient convenience and safety in mind. Yuhan said it uses a defibrillation protection circuit that delivers more than 99% of treatment energy to the patient while allowing measurements to resume within five seconds after a shock.
The product received U.S. Food and Drug Administration 510(k) clearance last year and earned the highest electrical safety rating under the international medical device safety standard IEC 60601-1, known as “Type CF Defib-proof.”
A Yuhan official said the company expects the monitoring system, with accurate alarms and rapid response, to help hospitalized patients recover.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.